Not Yet Recruiting PHASE1 INTERVENTIONAL 2-arm
NCT07433452
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers. (PSILOBIOMARKER)
Sponsor: Gabriella Gobbi
Conditions
Healthy Participants Placebo - Control Psilocybin
Interventions
Placebo Psilocybin (drug)
Updated 1 time since 2026 Last updated: Feb 19, 2026 Started: Sep 1, 2026 Primary completion: Sep 1, 2028 Completion: Sep 1, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Healthy Participants and Placebo - Control, this trial is actively recruiting participants. The trial is conducted by Gabriella Gobbi and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Gabriella Gobbi
Data source: McGill University Health Centre/Research Institute of the McGill University Health Centre
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.